Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Nashville TN, Fayetteville GA, Anderson SC,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Yoga for Pediatric Tension-Type Headache
for
Headache
Location: Nashville TN
Sponsor: Matthew Morris
Sex: All
Age: 13 - 18
Code: NCT03166358
Recruiting
ELEVATE-HFpEF Clinical Study
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Nashville TN, Louisville KY, Atlanta GA, Charleston WV,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All
Age: 40+
Code: NCT06678841
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Nashville TN, Carmel IN, St Louis MO, West Columbia SC,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Denver CO, Sarasota FL, Nashville TN, Fairfax VA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07066657
Phase 1, Recruiting
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
for
Ovarian Cancer, Endometrial Cancer,
Location: Nashville TN, Fairfax VA, Orlando FL, Irving TX,
Sponsor: ArriVent BioPharma, Inc.
Sex: Female
Age: 18+
Code: NCT07755436
Phase 1, Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,